Zosano Pharma (ZSAN) Misses Q2 EPS by 10c

Zosano Pharma (NASDAQ: ZSAN) reported Q2 EPS of ($0.63), $0.10 worse than the analyst estimate of ($0.53). Revenue for the quarter came in at $68 thousand versus the consensus estimate of $1.78 million.

For earnings history and earnings-related data on Zosano Pharma (ZSAN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c